1. Home
  2. AMBO vs PMCB Comparison

AMBO vs PMCB Comparison

Compare AMBO & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

HOLD

Current Price

$2.33

Market Cap

7.2M

Sector

Real Estate

ML Signal

HOLD

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.76

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBO
PMCB
Founded
2000
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
8.3M
IPO Year
2010
2001

Fundamental Metrics

Financial Performance
Metric
AMBO
PMCB
Price
$2.33
$0.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.1K
159.3K
Earning Date
08-05-2025
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
337.04
277.22
EPS
0.02
N/A
Revenue
$9,469,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$98.59
N/A
Revenue Growth
0.82
N/A
52 Week Low
$1.47
$0.63
52 Week High
$6.75
$1.51

Technical Indicators

Market Signals
Indicator
AMBO
PMCB
Relative Strength Index (RSI) 55.28 58.16
Support Level $1.97 $0.65
Resistance Level $2.43 $0.80
Average True Range (ATR) 0.27 0.07
MACD 0.03 0.00
Stochastic Oscillator 64.32 66.10

Price Performance

Historical Comparison
AMBO
PMCB

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Share on Social Networks: